Capricor Therapeutics
CAPR
CAPR
19 hedge funds and large institutions have $2.29M invested in Capricor Therapeutics in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
30% less capital invested
Capital invested by funds: $3.25M → $2.29M (-$964K)
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$17K | |
| 2 | +$8.09K | |
| 3 | +$1.91K | |
| 4 |
AG
Advisor Group
Phoenix,
Arizona
|
+$1K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$918 |
Top Sellers
| 1 | -$224K | |
| 2 | -$49.3K | |
| 3 | -$16K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.95K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$775 |